ESR1 p.Ser118Pro
c.352T>C · rs200075329 · VCV790988
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0835 | likely benign |
|---|---|---|
| REVEL | 0.152 | moderately benign-leaning |
| SaProt | LLR -5.92 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6 | GERP 1.4, phastCons 1 |
| Regional constraint | o/e 1.02 | unconstrained · MANE · 35 kb · p 0.76 · regional, not allelic |
| Overall | ||
| CADD | 23.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 1.66% | 60 |
| European (non-Finnish)grpmax | 0.476% | 210 |
| Admixed American | 0.406% | 246 |
| Remaining individualsnot grpmax-eligible | 0.38% | 263 |
| Middle Eastern | 0.0703% | 1,423 |
| African / African-American | 0.0657% | 1,523 |
| South Asian | 0.0426% | 2,349 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00697% | 14,356 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ESR1
- Protein
- p.Ser118Pro
- Coding
- c.352T>C
- MANE Select
- NM_000125
- dbSNP
- rs200075329
- Type
- single nucleotide variant
- Location
- chr6:151808264 (GRCh38)
- Gene constraint
- LOEUF 0.456 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 67.14 · 492 PDB
- Residue 118
- a modified residue (phosphoserine); the 'modulating (transactivation af-1); mediates interaction with macrod1' region; the 'interaction with ddx5; self-association' region
Similar variants
- SYNE1 p.Arg8746Ter Pathogenic/Likely pathogenic ★★ same type
- ESR1 p.Lys299Arg Uncertain significance ★★ ⚠ same type
- SYNE1 p.Arg8735Leu Uncertain significance ★★ ⚠ same type
- SYNE1 p.Arg8738His Uncertain significance ★★ ⚠ same type
- SYNE1 p.Arg8746Gln Uncertain significance ★★ same type
- SYNE1 p.Arg8782Gln Uncertain significance ★★ same type
- SYNE1 p.Arg8782Gly Uncertain significance ★★ same type
- SYNE1 p.Asp8725Asn Uncertain significance ★★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/esr1-p-ser118pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown